Cancer Research, Carlo Croce, Character Assassination, Civil Death, Clare Francis, Data Fabrication, Data Falsification, Defamation, Defamation lawsuit, First Amendment to US Constitution, Fraud, Ivan Oransky, National Institutes of Health, New York Times, NIH, NIH funding, Office of Research Integrity, Ohio State University, Paul S. Thaler, protected free speech, Research misconduct, Retraction Watch, Scientific corruption, Scientific publication

Stellar cancer researcher Carlo Croce falls from grace: hypocrisy in science

Last week The New York Times published a front-page story entitled “Years of Ethics Charges but Star Cancer Researcher Gets a Pass“.  The article grossly disparages Prof. Carlo Croce, a towering figure in cancer biology and genetics, and his home institution, The Ohio State University. It describes in some detail multiple accusations of misconduct and malfeasance that have been targeting Croce for years.

bio_croce

Dr. Carlo M. Croce, Ohio State University

We are told that Croce has been dodging grave allegations that he falsified data in research supported by more than $86 million in federal grants that have been awarded to him. The investigative task of the Times reporters was greatly facilitated by the fact that the records at Ohio’s courthouses and its university system are completely open to the public. And Ohio State University, which claims it had spent more money supporting Dr. Croce’s research than it had received in grants, was apparently totally responsive to requests for records.

The big problem with all this is that to this day there is no hard evidence of misconduct implicating Croce. Ohio State had repeatedly investigated Croce and cleared him of wrongdoing every single time. How disinterested these investigations were is of course a matter of debate.

Since Dr. Carlo Croce has not been proven guilty of misconduct by the preponderance of evidence, the public does not have the right to know about these investigations and he must be presumed innocent. The integrity of Croce’s career should have been protected. The New York Times article is actionable in Court.

The most astonishing aspect of the story is that neither government agencies nor Ohio State believed Croce would be seriously investigated for misconduct, since he is one of Ohio State biggest rainmakers. This bespeaks of a system corrupt to the marrow and draws a lesson that epitomizes the level of hypocrisy that plagues the science establishment.

Of course we wonder who sent James Glanz, the Times reporter, the documents that appeared in Mr. Glanz’s email inbox, in what his collaborator Agustin Armendariz calls three big dumps. This is anyone’s guess. The Times story mentions Clare Francis, the pseudonym for an agent for the blog Retraction Watch, whose brash nauseating style is reminiscent of Ivan Oransky’s writing…

In any case, that would be discovered in Court if and when Dr. Carlo M. Croce decides to take legal action.

Standard
Blog, Character Assassination, Clare Francis, Defamation, Defamation lawsuit, Expression of concern, Hilda Bastian, lawsuit, Mass hysteria, McCarthyism, National Institutes of Health, NCBI, NIH, NLM, Office of Research Integrity, Paul S. Thaler, Post publication peer review, Post Publication Peer Review Scam, Reporting Retractions, Research Integrity, Research misconduct, Retraction, Retraction Watch, Scientific corruption, Scientific Misconduct, Scientific publication, Scientific Reproducibility

Handling scientific post-publication events: Legal action required

Hilda Bastian is an NIH contractor for PubMed Health and PubMed Commons at the National Center for Biotechnology Information (NCBI), U.S. National Library of Medicine (NLM). She also seems to be a prolific science writer. Bastian recently informed the blog Retraction Watch that the NLM is planning a prominent display of Expressions of Concern (EoC) published by scientific journals. By her own admission, Hilda Bastian is not versed in scientific matters. Given what she intends to do, let us hope she is versed in legal matters, or at least willing to seek legal advice.

In the US, as in most societies under the rule of law, a person is deemed innocent unless proven guilty, and any suggestion that may affect someone’s reputation without hard proof constitutes defamation. By Bastian’s own admission, only about 25% of EoCs typically result in retraction. This begs the question: What do the authors whose papers received the remaining 75% of EoCs plan to do?

Lawyer Paul S. Thaler, a towering figure in scientific integrity may be the ideal person to assist such people determine their legal options. Paul S. Thaler made the following enlightening remark:

The first thing to remember is that the federal regulations, as well as the internal policies of most institutions, protect the confidentiality of respondents in research misconduct matters.  Thus, as a matter of federal law, institutions are prohibited from disclosing the identity of an accused scientist, except on a “need to know” basis, for example, to a member of the investigation committee, unless and until a finding of research misconduct is made.  These proceedings are not public as court is in criminal and civil disputes.  It is more comparable to proceedings against other professionals, such as lawyers, who are governed by their licensing organization.  Privacy in these matters is critically important as there is no public need to, or right to know, about professionals simply accused of wrongdoing.  What the public has a right to know about is a professional who has been found responsible for wrongdoing.  At that point, the public is alerted.  But because a professional’s reputation is so important to his or her career, the specter of an accusation can permanently stain that reputation and frequently the accusation is not well founded.  So the confidentiality of the process allows a full examination before the public is made aware.  We certainly do want to know about those scientists who have actually done something wrong that impacts science, but we do not, and should not, be concerned with those who are good scientists but caught up in a sometimes very political, internal dispute.

The bold section is crucial because it implies that EoCs are in all likelihood illegal, and so is the dissemination of such statements. The public does not have the right to know about mere accusations of wrongdoing, or suspicions of invalid data resulting in EoCs. According to Hilda Bastian such EoCs are likely to be wrong in 75% of the cases. For example, pseudonymous Clare Francis, the venal whistle-blower of Retraction Watch, has scored plenty of false positives eliciting EoCs mostly in the 75% of valid papers. Yet we are not aware that Retraction Watch or other related venues have been sued yet. Hopefully, Hilda Bastian will reflect about her plans and seek legal advice before charging ahead.

 

 

 

Standard
Anonymous Commenter, Clare Francis, Defamation lawsuit, First Amendment, Joshua Cherry, Joshua L. Cherry, Joshua L. Cherry NIH, Nature, NCBI, NIH, Post publication peer review, Post Publication Peer Review Scam, PubPeer, Reputation Damage, Research Integrity, Scientific corruption

The Travesty of Post Publication Peer Review

 It is well known that Chinese people have a practical and pragmatic bent. I recall having asked a successful professor what it would take to publish in Nature. He replied:

“You need to do very good work, make a lot of friends in your field and, above all, make sure to befriend the editors. To secure publications in good journals it is always best to start a courtship with the editors, find out what gets them excited. This approach often bears fruit.”

The whole publishing game seemed quite cynical to me at the time. Eventually, that conversation lead me to quit science altogether.

An untold truth in science is that success rests primarily on who you know, rather than on the merits of your work. Not surprisingly, the mechanism to protect the integrity of research reporting, the peer review (PR) system, has turned into a true scam, corrupt to the marrow. The anonymity of the PR process, implemented originally to guarantee freedom of opinion, in practice has become a vehicle for reviewers to promote their self-serving agenda, encouraging ax-grinding by the author’s competitors and complacency by the author’s friends. Editors contribute substantively to the scam by cherry-picking reviewers for the authors they like and rejecting papers without even sending them out for review (often to reduce their workload) whenever the author is not perceived as influential enough to bring them some benefit by treating him well.

If PR is a scam, post-publication peer review (PPPR) is a travesty to a grotesque degree. Here we don’t even know if the reviewers are the actual peers of scientists or simply angry frustrated people trying to bring down the authors. Our own polls conducted on 11 scientific publishers reveal that over 90% of anonymous PPPR is not pursued by the journals after it is found to be frivolous.  At least in PR, the journal editors are entrusted by the scientific establishment with picking reviewers who are supposed to be the author’s peers. But with PPPR, anything goes, as people with no verifiable credentials are allowed to hide in their anonymity to take comfortable shots at whoever they pick as their target.  At Science Transparency we have identified one such sniper: Joshua L. Cherry, the NIH/NCBI contractor still on the loose.

PPPR has thus turned into a farce where anyone gets to say anything, no matter how crass his views are. The channel for these people is the internet, the vast repository where angry people get to pour their vitriol and get the feeling that they are being heard. This matter is admirably described in an article entitled “Why Is Everyone on the Internet So Angry?” that seeks to identify the psychological root of the problem.

Of course, the root of the PPPR phenomenon and the anger it promotes can be found in the internet. “These days, online comments have become extraordinarily aggressive without resolving anything,” said Art Markman, a professor of psychology at the University of Texas at Austin.  Yet, the possibility of an anonymous attack offers a vehicle of self-realization for the frustrated scientist, and the internet enables this possibility and enables the person to be heard, finally! This emboldens him and fuels his anger.

Standard
美国国立卫生研究院, Howard Hughes Medical Institute, John Ioannidis, National Institutes of Health, NIH, NIH funding, Peer Review, Principal Investigator, Research grant, Study Section

Peer Review: Is NIH Rewarding Talent?

In a striking analysis published in Nature, Stanford University researcher John Ioannidis, the expert on metadata investigation at the Stanford Prevention Research Center, has seriously questioned the way the National Institutes of Health fund research proposals. He and his colleague Joshua Nicholson have argued in what seems like a rousing condemnation of the status quo that peer-review, the process by which study sections review and rank research applications, is totally broken.  The researchers argued that peer review at NIH (简称) encourages “conformity, if not mediocrity”, favoring proposals submitted by people who know how to network and play the petty games of academic sociology, rather than those by people who have original and potentially influential ideas.

These conclusions rest heavily on the observation that only 40 percent of scientists with highly cited papers (say, those with more than 1000 citations) are principal investigators on NIH grants. That is, those scientists whose peers value their work most highly are often not receiving NIH support for that work.

Of course, the analysis may be imperfect. Here is my critique for one: Using high citation level as a proxy for originality is probably not entirely correct (but then what is a good proxy for originality?). It is also possible that a good percentage of these investigators have not even applied for NIH funding in the first place. And, finally, they may have other sources of support for their research, most likely, the Howard Hughes Medical Institute (should we then conclude that HHMI funds more original research than NIH?).

It is perhaps true that the peer review system is broken. The majority of the authors of the most influential papers in medicine and the life sciences seem not to have NIH funding according to Ioannidis and Nicholson, and their funding rate is possibly less than average. Perhaps the most disturbing observation, the one that truly needs the closest scrutiny, is that study section members are almost always funded while their citation impact is typically low or average: they are not the high-impact innovators.

This leaves us with a sad reflection. Probably a truly innovative idea cannot be appreciated by the peers, while if peers can readily grasp it (to the level they are willing to fund it), it is probably not innovative.

NIH is seemingly aware of this problem and has earnestly tried to address these concerns introducing specific award categories such as the Pioneer and New Innovator Awards. Perhaps Ioannidis and Nicholson may be willing to evaluate the efficacy of these categories in capturing true talent.

Standard
Argentina, Ariel Fernandez, Ariel Fernandez book, Ariel Fernandez Publications, Ariel Fernandez Research, Dehydron, 阿列尔·费尔南德斯, Hasselmann Professor at Rice University, Joshua Cherry, Joshua L. Cherry, Joshua L. Cherry NIH, Michael Lynch, Nature, Nature Addenda, NIH, Republic of China, Rice University News, Sze-Bi Hsu, Taiwan, Tsing-Hua University, Wen-Hsiung Li

The Nature-Related Research by Ariel Fernandez at the Republic of China

“Residents and interns worked a lot of hours, and I wrote honestly about what it was like to be an intern. One of the deans wasn’t crazy about that. It reminded me that my core identity is as a journalist, constantly challenging things…Blogs are powerful and lower the publishing barrier.”
Ivan Oransky

This post constitutes a bit of a digression but a justified one since the research I intend to discuss served as the basis for a professional paper recently exposed by junk journalism (see our previous entry). Here I vindicate Professor Ariel Fernandez (阿列尔·费尔南德斯), the discoverer of the dehydron (脱水元) and a remarkably creative and imaginative physical chemist and mathematician -as attested by his publications– who recently had his share of spats with the blog-based junk journalism. I am specifically referring to the coverage of the so-called “post-publication peer review” of one of the doctor’s papers in Nature (see the previous post). This paper was challenged by Joshua Cherry, a person of unreported and unverified employment at NIH. Joshua Cherry corresponded extensively with Ariel Fernandez before deciding to operate hiding in anonymity once Dr. Fernandez alerted him that he needed to learn the subject before writing reviews. The blog-based type of journalism that covered the Nature story is completely unedited, not subject to scientific peer review and not subject to the most elementary standards of science. Driven by angry nobodies seeking notoriety, the Marcus-Oransky blog lies outside the scientific establishment, actually doing a disservice to science. Internet enables the exchange of information at unprecedented levels, but it also enables any person, however deranged, to pour his or her madness, and make it universally accessible without even having to disclose his or her identity. Fortunately, the majority of scientists do not take such journalism any more seriously that they would take a blog on the healing powers of the pyramids.

oransky fernandez
The source of the picture on the left is this article at Yale Medicince.

Dr. Ariel Fernandez is no stranger to Chinese audiences (Wikipedia Biosketch for Ariel Fernandez in Mandarin). I first became acquainted with him in 2008, when he delivered a lecture (poster and announcement below) at the Genomics Research Center in Academia Sinica, Republic of China. His host at the time was none other than Wen-Hsiung Li, the James Watson Professor at the University of Chicago and a towering figure in the field of molecular evolution. On that occasion, Ariel Fernandez lectured on the exploitation of evolutionary concepts to optimize drug design, an extremely original idea. The lecture introduced the key concept of dehydron, a sticky structural defect in proteins that is not conserved across homologous proteins. This lack of conservation makes dehydrons crucial selectivity filters for drug discovery, an idea later fleshed out in Ariel Fernandez’s first book “Transformative Concepts for Drug Design: Target Wrapping“. It was a mesmerizing lecture.

Ariel Fernandez lectures at Academia Sinica

Ariel Fernandez lecture announcement

Our second encounter took place in Hsinchu the next year, in 2009, when Ariel Fernandez began a series of visits to the National Tsing-Hua University sponsored in part by the Ministry of Education of the Republic of China (see illustration below). These visits hosted by Mathematics professor Sze-Bi Hsu led to the maturation of a revolutionary idea: introducing insights from structural biology into evolutionary biology, turning the latter more quantitative and precise. These thoughts eventually led to the Nature paper formerly coauthored by Michael Lynch. The seminal ideas by Ariel Fernandez at the National Tsing-Hua University, together with their ramifications in the field of aberrant aggregation-related disease, were enthusiastically reviewed at that institution, as shown in their “high-scope article” here.

Ariel Fernandez at Tsing-Hua University

Ironically, it was Michael Lynch who heralded these discoveries in auspicious terms. Thus, in 2009, Lynch had this to say to Rice University News and Media:
“One aspect of Ariel Fernandez’s research that is potentially groundbreaking is the observed tendency of proteins to evolve a more open structure in complex organisms”.
“This observation fits with the general theory that large organisms with relatively small population sizes — compared to microbes — are subject to the vagaries of random genetic drift and hence the accumulation of very mildly deleterious mutations”.

The liason of Ariel Fernandez with the Republic of China seems to be a long-lasting one. We are indeed fortunate that he has become a frequent visitor to the Mathematics Division at the National Center for Theoretical Science. His lecture last year is still announced here.

Taiwan lecture 1

It is not uncommon to see him announced on short notice, like in the poster below for an inpromptu lecture at Chiao Tung University on recent developments of the ideas he first brought to us at Academia Sinica five years earlier.

Ariel Fernandez Chiao Tung Univ

Dr. Fernandez, come back. We miss you!

RELATED READING:

Ariel Fernandez, Nature 474, 502-505 (2011)

Ariel Fernandez Innovation

Ariel Fernandez Consultancy

Wikipedia Biosketch of Ariel Fernandez in Mandarin

Ariel Fernandez featured in Baidu Encyclopedia (Mandarin)

Ariel Fernandez Scientist/Consultant

Ariel Fernandez Blog

Ariel Fernandez Book

Ariel Fernandez CV

Ariel Fernandez Google Scholar Citations

Ivan Oransky at Yale Medicine

Ariel Fernandez New Book (June 14, 2015)

 

Baidu 3

Ariel Fernandez featured in Baidu Encyclopedia.

 

RECENT COMMENTS (SEARCH UNDER COMMENTS)

LIPING says:
I love your inclusion of Oransky’s quote. In plain English it reads: SCIENCE IS HARD, TRASHING IT, AS WE DO AT RETRACTION WATCH, IS SO MUCH EASIER!
DECEMBER 6, 2014 AT 11:07 PM

WEISHI MENG says:
That is the translation, yes. Sad and tragic. It takes all kinds, I guess…
DECEMBER 6, 2014 AT 11:16 PM

TOBY says:
The towering Dr. Ariel Fernández is very good looking (was he photographed by El Greco or does he really share the build of a Mantis religiosa?), and Oransky is clearly a nasty bon viveur, jealous of the big man and who needs to start jogging if he wants to compete in the same scientific and glamorous world as our hero.
Also Oransky, learn one thing: one always has a better side for the pictures. Discover which one is yours and use it in all photos. Learn something from the aristos you good for nothing former headshrink!
DECEMBER 9, 2014 AT 1:38 PM

Standard
Adam Marcus, Argentina, Ariel Fernandez, Ariel Fernandez Publications, Ariel Fernandez Research, Ariel Fernandez ResearcherID, Buenos Aires, Cat Ferguson, 阿列尔·费尔南德斯, Ivan Oransky, Joshua Cherry, Joshua L. Cherry, Michael Lynch, Nature, Nature Addenda, NCBI, NIH, Peer Review, Post publication peer review, PubMed, Scientific publication, Scientific Research, Swiss Radio and Television, Weishi Meng on Ariel Fernandez

Post Publication: Interview with Dr. Ariel Fernandez on a Nature Paper Controversy (Ten more minutes added on 12/2)

As a glance at his CV reveals, Dr. Ariel Fernandez (阿列尔·费尔南德斯), the discoverer of the dehydron (脱水元), is a very creative physical chemist and mathematician, a key player in the recent biotechnology transformation. His research has been heralded in auspicious terms, as illustrated for example in this review published in Scientific American. The breadth of research accomplishments of Ariel Fernandez, ranging from abstract algebra to drug design is breathtaking and probably unheard of in science (see a linked version of his publication record). In his ResearcherID page, Thomson/Reuters estimated that Ariel Fernandez has published 485 professional articles, book chapters included. His innovative drug designs were enthusiastically received by eminent doctors such as Thomas Force (Vanderbilt University) and were also reported in laudatory terms, as shown for example in this review by legendary Harvard oncologist George Demetri. Quoting Dr. Demetri:

“The first generation of kinase-inhibitory drugs such as imatinib and sunitinib have already provided patients with life-saving therapeutic options, and with tools such as those described by Fernández et al., the future certainly looks bright for constructing ever-better agents that can be combined safely and effectively to manage, and eventually cure, many forms of human cancer”.

Dr. Ariel Fernandez

Dr. Ariel Fernandez

In a recent collaboration with eminent cardiologist Richard L. Moss, Dr. Ariel Fernandez came up with a potential treatment of heart failure by disrupting a myosin association with a myosin-regulatory protein, a novel invention recently awarded the US patent 9,051,387. You may find descriptions of this invention at: US Patent and Trademark Office page, Espacenet page, University of Wisconsin-Madison, Ariel Fernandez Consultancy, Academia.edu, Ariel Fernandez’s professional page.

In spite of this stellar career and in spite of his efforts to fight cancer and heart failure, Dr. Ariel Fernandez is not impervious to slander. In the new era of post publication peer review, where anybody says whatever they like without even revealing his identity or his credentials, Dr. Ariel Fernandez has been the target of libel. In this note, Dr. Ariel Fernandez reflects on post-publication peer review in light of a recent attack by journalist Ivan Oransky, the self-proclaimed champion of scientific transparency, who has been recently named Science’s Garbage Man (Muellsammler der Wissenschaft) by the Swiss Radio and Television. In his post, Oransky mentions a Note that Nature Editors appended as Addendum to a Nature paper by Ariel Fernandez.

oransky fernandez
The source of the picture on the left is this article at Yale Medicince.

WM: Thank you doctor for agreeing to talk to us on such short notice. What was your reaction to the recent post by Ivan Oransky (and Adam Marcus) published in their blog in regards to your Nature paper?

Ariel Fernandez: It is hard for me to understand the motivation for such posts by Ivan Oransky and Adam Marcus and for some of the comments in their blog. The story is thin on reality. It reads like an attack. These people seem angry (they surely sound angry) and probably think they will get some credit for doing what they do. Meanwhile, the science establishment is not taking the needed leadership in regards to post-publication assessment and in regards to fixing the peer review system.

WM: Why do you think Oransky dislikes you?

Ariel Fernandez: I don’t think our paths ever crossed, I don’t even know him. I heard he is a doctor, and that he is smart. There are many wonderful things that a smart doctor can do, what Oransky is doing is not one of them.

WM: Can you tell us what are the news exactly?

Ariel Fernandez: The Addendum published by the Nature Editors on my paper [Ariel Fernandez, Nature 474, pages 502-5 (2011)] exposes a controversy between the two authors of the paper, former author Michael Lynch and me. This is hardly a news item. Lynch and I have a disagreement on the data and what it means. The Nature addendum is appended to the paper at the url:

http://www.nature.com/nature/journal/v474/n7352/full/nature09992.html

I posted my own tutorial on the Nature paper, including the code, raw data and statistical analysis in compliance with the open data mandate. Anybody interested can help clarify the matter if he/she so choses.

WM: How did this problem originate?

Ariel Fernandez: As I recall, in November of 2011, a Joshua Cherry, a sort of contractor (?) at NIH/NCBI first contacted me indicating that he wanted to reproduce my data in the Nature paper. After exchanging dozens of mails, I offered him a tutorial, because I realized he had little or no background in biophysics. He rejected my tutorial and from then on began challenging my papers. Now, why would a person with no background in my field decide to challenge my papers is a mystery to me. This fellow Joshua Cherry is behind the attacks on my work and my person. He seems somewhat obsessed (?) with me for some reason. Now, from what I can see, Cherry has authored some reasonable papers on population dynamics, yet he invests heavily on the downfall of someone working in a field he knows nothing about?

WM: That is odd.

Ariel Fernandez: The most important lesson to be drawn from this incident requires that we all take the high ground and ask ourselves: How should post-publication peer review be conducted? I believe there is only one way which has been the way of science for centuries: If anyone feels the need to challenge a published paper, the person should send the comments to the journal where the original work was published, request that his/her comments be subject to peer review and if they pass peer review, the objections should be published side by side with the response by the original author for everybody to examine and draw conclusions. The rest, including Oransky’s blog, is just noise.

WM: Doctor, I heard rumors that you and I are the same person.

Ariel Fernandez: Well, let’s see. You surely sound quite different from me and I don’t have any Chinese ancestry to speak of…

WM: Thank you doctor, have a good evening.

Ten more minutes on the phone with Dr. Ariel Fernandez (12/2/2014)

07

WM: Did you read the comments at the blog run by Ivan Oransky and Adam Marcus?

Ariel Fernandez: I read a bunch, then it got too silly with the Meng-Fernandez duality and I took my dog for a walk. It made me sad that these people cannot seem to be able to take the high ground on the broad issues at stake.

WM: Yes, they seem to dwell on whether I am a real person or whether you are actually me, or dual realities, or God knows what. Totally immaterial, like asking whether the characters in Plato’s dialogues are real or fake and take away merit if the latter were the case (I prepared that one beforehand, by the way). So, what are the issues at stake?

Ariel Fernandez: As I see it, the only thing worth focusing on is the failure of the peer review system. If the system were water- tight, there would be no need for PPPR [post publication peer review], of course. There are core issues worth focusing on: lobbying, editor courtship, fake reviewers, and cronyism in the peer review system.

WM: Well, so what do we do then?

Ariel Fernandez: Many journals are simply too amateurish to lead in this crisis, and the absence of leadership in times of crisis, often leads to bad things as we all know too well. Opportunists take over, as history has shown time and again. A leadership void has been created concurrently with the peer review crisis and, quite opportunistically, the blog by Ivan Oransky and the other fellow fills in that void. It is a bad thing but it has managed to parasite over the space available, fits right in there. Tragically, everybody watches in complete stupor while these people run the agenda.

WM: OK, so what do we (you and me) do?

Ariel Fernandez: Well, we keep it up. We help them realize that there is a loftier pursuit than indulging in the trigger-happy nonsense of the blog. We try to educate the bloggers and commenters because we believe that there is a higher ground and that they can truly contribute. Oransky, for one, is possibly a very smart person and could do plenty of good.

WM: And the lofty pursuit is…

Ariel Fernandez: Help the establishment fix the peer review system by showing concrete failures of peer review and how we can learn from the mistakes to make improvements, how we can introduce better ways to safeguard the integrity of reported work with concrete working examples while fighting the problems alluded to previously. Above all, ensure that if and when PPPR becomes an absolute necessity, it is subject to the standards that science has upheld for centuries, since professional journals came into existence. In this pursuit there is no room for Ivan Oransky or the other fellow, or the commenters, unless they choose to get serious about fixing the system and stop being silly. Vulgarization of career mistakes and tragic turns of fortune is not going to get them anywhere (except in the eyes of the angry mob of losers in science who invest in the downfall of the winners). They need to help device clever ways to deal with and combat scientific corruption at its root.

WM: My pleasure again doctor, enjoy the rest of the day.

RELATED READING:

Ariel Fernandez and Michael Lynch (2011) Nature 474, 502-505

Disclaimer by Ariel Fernandez

Ariel Fernandez complete CV updated May 18, 2015

Ariel Fernandez featured in Baidu Encyclopedia (Mandarin)

Books by Ariel Fernandez

Ariel Fernandez at ResearchGate

Curriculum Vitae for Ariel Fernandez

The Peer Review Crisis by Ariel Fernandez

Rice University Faculty Catalogue

Ariel Fernandez Consultancy

Transformative Concepts for Drug Design: Target Wrapping, Book by Ariel Fernandez, Springer, 2010

Ariel Fernandez Professional Website

Biomedical Research by Ariel Fernandez, NIH

Standard
Adam Marcus, Anonymous Commenter, Cat Ferguson, Character Assassination, Corruption, Data Fabrication, Data Falsification, Hilda Bastian, Ivan Oransky, JATdS, Joshua Cherry, Leonid Schneider, Mass hysteria, Misconduct, NCBI, NIH, Peer Review, Post publication peer review, PubMed, PubMed Commons, Reporting Retractions, Reporting Science Retractions, Research Integrity, Retraction Watch, Retractions, Science, Scientific corruption, Scientific Misconduct, Scientific publication, Scientific Research, Suicide, Transparency

Retraction Watch tracks down scientific corruption. Huh?

We would like to believe that people associated with the practice of science regard the process of tracking down corruption in research as a worthy undertaking. We better be careful with what exactly we wish for because the emerging picture, as it stands today, is looking ugly and getting uglier: Corruption is far more frequent than we would like to admit and, depending on where you draw the line, the indicators show that it is probably rampant. In this regard, a great piece on reproducibility by science writer Philip Ball is particularly enlightening.

Be as it may, efforts to track down corruption appear to be ill fated, poorly conceived, with some of the players even more corrupt than the subjects they choose to condemn. In principle, post-publication peer review (PPPR) is a plausible vehicle to track down corruption when the latter is detectable in published research. In practice, PPPR has turned into a rogue operation driven by losers seeking to elevate themselves by bringing down established figures while creating the perception they are doing something useful. Unfortunately, the scientific establishment will need to get out of its lethargy and, until that happens, PPPR will remain mostly in the hands of blogs run by nobodies seeking notoriety.

Perhaps the most grotesque of these blogs – and by far the loudest – is the self-published Retraction Watch. This blog is run by Ivan Oransky and Adam Marcus, two self-proclaimed experts on retractions, science reporting complications, career-related suicides and other tragedies associated with corruption. These towering figures are assisted by Cat Ferguson, a formidable writer whose ability to report on corruption tragedies earned her an internship at Retraction Watch (they even got a bit of money contributed by their commenters).

Oransky
The source of the picture is this article at Yale Medicince.

A beacon of decorum and noblesse, Retraction Watch does not simply broadcast journal notifications, they distort the findings to a grotesque degree in order to smear or destroy reputations and take active steps single-handedly to ruin the careers of those that they find guilty of having committed some form of misconduct. Not surprisingly, Retraction Watch founder Ivan Oransky has been named Science’s Garbage Man (Muellsammler der Wissenschaft) by the Swiss Radio and Television. The agenda of Retraction Watch is pretty much dictated by the hysteria of its commenters, veritable nobodies seeking attention and hoping to be rewarded for “tracking down the phonies”, to paraphrase the assassin of John Lennon. Some of these commenters such as JATdS, Leonid Schneider, Neuroskeptic, etc. opine on most notifications, regardless of the subject matter (that is irrelevant to them) contributing veritable manifestos. Some of these manifestos are inflammatory, while others take a more sober tone, but all seem supremely irrelevant. In these harangues the commenters demand that the suspected wrong-doers be sent straight to the scaffolds, repudiating the tendency of the defendants to defend themselves or get “lawyered up”. In his blog, Ivan Oransky himself frequently laments the fact that people accused of misconduct often try to defend themselves and that the lawyers they engage are responsible for belated and opaque post-publication notifications. In his world, only the hysteria of his commenters should prevail as justice is delivered.

Ivan Oransky, the self-proclaimed champion of science transparency, has been a staunch protector of the anonymity of his Retraction Watch commenters. He advocates that they are entitled to anonymity invoking the protection of the information source in reporting. This is crass to the point where I find it difficult to imagine a worst aberration. Is he saying that he actually draws information from the hysterical frustration-triggered manifestos of the nobodies that comment on his blog?

A different model for PPPR was recently adopted by PubMed Commons, which is an NCBI/NIH-sponsored forum for post-publication discussion. To state that it is a vehicle for PPPR is actually misleading since the comments at PubMed Commons are NOT subject to peer review. At least the fact that the authors are required to disclose their identity makes PubMed Commons more moderate and balanced than the atrocious Retraction Watch. There is one thing that Retraction Watch and PubMed Commons have in common and that is that they are both irrelevant and inconsequential to science precisely because their contributions are not peer reviewed and would not pass the acid test of science. The most avid contributor to PubMed Commons is… -you guessed it!- Ivan Oransky, who constantly needs to boost his internet presence and affirm his reputation and probably sees his blog Retraction Watch driven to oblivion by PubMed Commons. Other avid contributors are Hilda Bastian a science writer and editor for PubMed Health, who like most science writers, needs to aggrandize her presence on the web, and Joshua Cherry, a scientist? (contractor?) of unverifiable employment at NCBI/NIH who seems to find plenty of time to harangue other scientists with his meta-arguments.

It is hard to imagine that Joshua Cherry or the other individuals mentioned in this post truly believe that their comments constructively enrich the post-publication record. They simply cannot be that delusional.

Things must change with PPPR but this is unlikely to happen unless the science establishment recovers from its lethargic state and begins to act responsibly in the face of corruption.

Standard